Eschenhagen T - Search Results

1

Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study.

Rau T, Wuttke H, Michels LM, Werner U, Bergmann K, Kreft M, Fromm MF, Eschenhagen T. Rau T, et al. Among authors: eschenhagen t. Clin Pharmacol Ther. 2009 Mar;85(3):269-72. doi: 10.1038/clpt.2008.218. Epub 2008 Nov 26. Clin Pharmacol Ther. 2009. PMID: 19037197

2

Transient expression of NMDA receptor subunit NR2B in the developing rat heart.

Seeber S, Becker K, Rau T, Eschenhagen T, Becker CM, Herkert M. Seeber S, et al. Among authors: eschenhagen t. J Neurochem. 2000 Dec;75(6):2472-7. doi: 10.1046/j.1471-4159.2000.0752472.x. J Neurochem. 2000. PMID: 11080199 Free article.

3

Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.

Heubach JF, Rau T, Eschenhagen T, Ravens U, Kaumann AJ. Heubach JF, et al. Among authors: eschenhagen t. Br J Pharmacol. 2002 May;136(2):217-29. doi: 10.1038/sj.bjp.0704700. Br J Pharmacol. 2002. PMID: 12010770 Free PMC article.

4

Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment.

Rau T, Heide R, Bergmann K, Wuttke H, Werner U, Feifel N, Eschenhagen T. Rau T, et al. Among authors: eschenhagen t. Pharmacogenetics. 2002 Aug;12(6):465-72. doi: 10.1097/00008571-200208000-00007. Pharmacogenetics. 2002. PMID: 12172215

5

Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.

Wuttke H, Rau T, Heide R, Bergmann K, Böhm M, Weil J, Werner D, Eschenhagen T. Wuttke H, et al. Among authors: eschenhagen t. Clin Pharmacol Ther. 2002 Oct;72(4):429-37. doi: 10.1067/mcp.2002.127111. Clin Pharmacol Ther. 2002. PMID: 12386645

6

Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes.

El-Armouche A, Rau T, Zolk O, Ditz D, Pamminger T, Zimmermann WH, Jäckel E, Harding SE, Boknik P, Neumann J, Eschenhagen T. El-Armouche A, et al. Among authors: eschenhagen t. FASEB J. 2003 Mar;17(3):437-9. doi: 10.1096/fj.02-0057fje. Epub 2003 Jan 2. FASEB J. 2003. PMID: 12514122

7

Overexpression of wild-type Galpha(i)-2 suppresses beta-adrenergic signaling in cardiac myocytes.

Rau T, Nose M, Remmers U, Weil J, Weissmüller A, Davia K, Harding S, Peppel K, Koch WJ, Eschenhagen T. Rau T, et al. Among authors: eschenhagen t. FASEB J. 2003 Mar;17(3):523-5. doi: 10.1096/fj.02-0660fje. Epub 2003 Jan 21. FASEB J. 2003. PMID: 12631586

8

24-h Langendorff-perfused neonatal rat heart used to study the impact of adenoviral gene transfer.

Wiechert S, El-Armouche A, Rau T, Zimmermann WH, Eschenhagen T. Wiechert S, et al. Among authors: eschenhagen t. Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H907-14. doi: 10.1152/ajpheart.00856.2002. Epub 2003 Mar 27. Am J Physiol Heart Circ Physiol. 2003. PMID: 12663262 Free article.

9

Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure.

El-Armouche A, Zolk O, Rau T, Eschenhagen T. El-Armouche A, et al. Among authors: eschenhagen t. Cardiovasc Res. 2003 Dec 1;60(3):478-87. doi: 10.1016/j.cardiores.2003.09.014. Cardiovasc Res. 2003. PMID: 14659793 Review.

10

[Genetic polymorphisms in drug metabolizing enzymes--impact on treatment with beta-blockers].

Wuttke H, Rau T, Eschenhagen T. Wuttke H, et al. Among authors: eschenhagen t. Dtsch Med Wochenschr. 2004 Apr 8;129(15):831-5. doi: 10.1055/s-2004-823030. Dtsch Med Wochenschr. 2004. PMID: 15054690 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters